NCT02465632 - To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris. | Biotech Hunter

Enrollment

1,100

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions

Acne Vulgaris

Interventions

DRUG

Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel

DRUG

BenzaClin® Topical Gel, Clindamycin 1%/Benzoyl Peroxide 5%

DRUG

Placebo

Trial Locations (15)

Glenmark Investigational Site 13, Anaheim

Glenmark Investigational Site 6, Long Beach

Glenmark Investigational Site 15, Los Angeles

Glenmark Investigational Site12, West Covina

Glenmark Investigational Site 4, Brandon

Glenmark Investigational Site 1, Miami

Glenmark Investigational Site 8, Miami

Glenmark Investigational Site 9, Miramar

Glenmark Investigational Site 2, St. Petersburg

Glenmark Investigational Site 5, Louisville

Glenmark Investigational Site7, Upper Saint Clair

Glenmark Investigational Site 14, Greenville

Glenmark Investigational Site 3, Nashville

Glenmark Investigational Site 10, Belize City

Glenmark Investigational Site 11, Belize City